In vitro genotoxicity assessment of biosynthesized zinc oxide nanoparticles

ArticleAçık Erişim

Özet

There are various studies on the toxicological potentials of conventionally synthesized zinc oxide (ZnO) nanoparticles, which are useful tools for many medical applications. However, knowledge about the biologically synthesized ones is still limited. In this study, the potential of producing ZnO nanoparticles via a green synthesis method, which enables safer, environmentally, economical and controlled production by using the Symphoricarpos albus L. plant, was investigated. For this purpose, aqueous extract was obtained from the fruits of the plant and reacted with zinc nitrate precursor. Characterization of the synthesized product was carried out by SEM and EDAX analyzes. In addition, the biosafety of the product was also investigated by using the Ames/Salmonella, E. coli WP2, Yeast DEL, seed germination, and RAPD test systems. The results obtained from SEM studies showed that spherical nanoparticles with an average diameter of 30 nm were synthesized as a result of the reaction. EDAX findings confirmed that these nanoparticles were composed of Zn and O elements. On the other hand, according to the findings of the biocompatibility tests, the synthesized nanoparticle did not show any toxic and genotoxic effects up to a concentration of 640 μg/ml in any of the test systems. Accordingly, considering the findings of our study, it was concluded that the aqueous extract of S. albus fruits can be used for the green synthesis of ZnO nanoparticles, the products obtained successfully passed the biocompatibility tests in our study, and additionally, more comprehensive biocompatibility tests should be performed before industrial scale production. © The Author(s) 2023.

Anahtar Kelimeler

RDL Kalıcı Bağlantı (PID)
https://rdlopen.rawdatalibrary.net/r/ebyu/12146Resmi atıflarda kullanılan kalıcı adres
DOI
https://doi.org/10.1177/07482337231173727Yayıncı resmi DOI adresi
Tam Kayıt
AlanDeğerDil
dc.contributor.authorDemir, Abdussamed Yasin
dc.contributor.authorKaradayi, Mehmet
dc.contributor.authorIsaoglu, Mine
dc.contributor.authorKaradayi, Gokce
dc.contributor.authorGulluce, Medine
dc.date.accessioned2026-10-18T20:27:05.272298338Z
dc.date.available2026-10-18T20:27:05.272298338Z
dc.date.issued2023
dc.description.abstractThere are various studies on the toxicological potentials of conventionally synthesized zinc oxide (ZnO) nanoparticles, which are useful tools for many medical applications. However, knowledge about the biologically synthesized ones is still limited. In this study, the potential of producing ZnO nanoparticles via a green synthesis method, which enables safer, environmentally, economical and controlled production by using the Symphoricarpos albus L. plant, was investigated. For this purpose, aqueous extract was obtained from the fruits of the plant and reacted with zinc nitrate precursor. Characterization of the synthesized product was carried out by SEM and EDAX analyzes. In addition, the biosafety of the product was also investigated by using the Ames/Salmonella, E. coli WP2, Yeast DEL, seed germination, and RAPD test systems. The results obtained from SEM studies showed that spherical nanoparticles with an average diameter of 30 nm were synthesized as a result of the reaction. EDAX findings confirmed that these nanoparticles were composed of Zn and O elements. On the other hand, according to the findings of the biocompatibility tests, the synthesized nanoparticle did not show any toxic and genotoxic effects up to a concentration of 640 μg/ml in any of the test systems. Accordingly, considering the findings of our study, it was concluded that the aqueous extract of S. albus fruits can be used for the green synthesis of ZnO nanoparticles, the products obtained successfully passed the biocompatibility tests in our study, and additionally, more comprehensive biocompatibility tests should be performed before industrial scale production. © The Author(s) 2023.
dc.identifier.doi10.1177/07482337231173727
dc.identifier.eissn1477-0393
dc.identifier.endpage355
dc.identifier.issn0748-2337
dc.identifier.issue7
dc.identifier.pmid37156264
dc.identifier.scopus2-s2.0-85159103380
dc.identifier.startpage345
dc.identifier.urihttps://rdlopen.rawdatalibrary.net/r/ebyu/12146
dc.identifier.volume39
dc.identifier.wosWOS:000984231800001
dc.language.isoen
dc.publisherSAGE Publications Ltd
dc.relation.ispartofToxicology and Industrial Health
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectbiosynthesis
dc.subjectgenotoxicity
dc.subjectnanogenotoxicity
dc.subjectSymphoricarpos albus
dc.subjectZnO nanoparticle
dc.subjectAnti-Bacterial Agents
dc.subjectEscherichia coli
dc.subjectMetal Nanoparticles
dc.subjectMicrobial Sensitivity Tests
dc.subjectNanoparticles
dc.subjectPlant Extracts
dc.subjectRandom Amplified Polymorphic DNA Technique
dc.subjectZinc Oxide
dc.subjectzinc oxide nanoparticle
dc.subjectantiinfective agent
dc.subjectmetal nanoparticle
dc.subjectnanoparticle
dc.subjectplant extract
dc.subjectArticle
dc.subjectbiocompatibility
dc.subjectbiosafety
dc.subjectcontrolled study
dc.subjectenergy dispersive X ray spectroscopy
dc.subjectgermination
dc.subjectgreen chemistry
dc.subjectin vitro study
dc.subjectnonhuman
dc.subjectparticle size
dc.subjectrandom amplified polymorphic DNA
dc.subjectSalmonella
dc.titleIn vitro genotoxicity assessment of biosynthesized zinc oxide nanoparticles
dc.typeArticle
dspace.entity.typePublication
rdl.citation.scopus6
rdl.citation.wos6
rdl.departmentDepartment of Medical Genetics, Medical Faculty, Erzincan Binali Yıldırım University, Erzincan, Turkey.
rdl.oa.statusopen
rdl.source.indexSCOPUS
rdl.source.indexWOS
rdl.source.indexPUBMED
rdl.wos.indexScience Citation Index Expanded (SCI-EXPANDED)